Jayanth Life Sciences Private Limited - Due diligence report

A 360° intelligence report on Jayanth Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, grow…

2011-03-14 Hyderabad, Telangana Active Unlisted Active Compliant
Share
View plans Plan
JL Jayanth Life Sciences Private Limited
View plans Plan
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Jayanth Life Sciences Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
68/100
Trust Score
Moderate

Jayanth Life Sciences Private Limited is assessed as Moderate with a Trust Score of 68/100. Jayanth Life Sciences Private Limited is an active private limited indian non-government company incorporated in 2011, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.

Report generated on 13 Jul 2026 from the latest processed filings. Jayanth Life Sciences Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Neutral

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
68/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
51/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
30/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 30/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 1.42).
  • Profitable - internal accruals available.

Charges position: 5 open (13.16 cr) · 2 satisfied (20.24 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others2 48.0 cr
Indian Bank2 48.0 cr
Hdfc Bank Limited2 48.0 cr
Axis Bank Limited1 48.0 cr
Compliance Score: 51/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Flagged by authority: EPFO.
  • Litigation present in 1 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
KOTI REDDY BAIREDDY 01234567 Director 01/04/2018 6 yrs Approved
BAIREDDY JAYA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2019 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
5 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 75 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 15+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Compliance score is weak (51/100).
5 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence63/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment41/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 5 open charge(s) of 13.16 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view64/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
12 Sep 2025
Charge created
Others - 12.00 cr
30 Sep 2024
Last AGM held
Annual general meeting
03 May 2024
Charge satisfied
Axis Bank Limited
31 Mar 2024
Latest balance sheet
Filed with ROC
20 Jun 2023
Charge created
Indian Bank - 33.88 Lakh
28 Apr 2023
Charge created
Indian Bank - 50.00 Lakh
10 Aug 2022
Charge created
Hdfc Bank Limited - 11.99 Lakh
05 Jul 2022
Charge created
Hdfc Bank Limited - 19.99 Lakh
06 Jan 2021
Director ceased
PAVAN KUMAR REDDY BEERAVELLI
Director ceased
ARANI BEERAVELLI
07 Apr 2020
Director ceased
NAIDU DURGA PRASAD
19 Nov 2019
Charge created
Axis Bank Limited - 19.16 Lakh
29 Apr 2019
Director ceased
BAIREDDY KOTI REDDY
27 Apr 2019
Director appointed
KOTI REDDY BAIREDDY (Director)
17 Nov 2018
Charge satisfied
Others
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - leverage worth monitoring.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2019 annual return.
Capital has been raised through 5 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Vinsent Crop Science Chemical Private Limited U24219GJ2010PTC059514 Mansa, Gujarat, India
Oyster Chemicals Private Limited U24100HR2010PTC040973 Gurgaon, Haryana, India
Annex Pharmaceutical & Chemicals Private Limited U24119MH2006PTC161700 Mumbai, Maharashtra, India
Waves Bio-Tech Pvt Ltd U24239DL2001PTC111836 New Delhi, Delhi, India
Decotouch Paints U24100DL2010PLC211180 Delhi, Delhi, India
Fine Processors Private Limited U25209DL1998PTC097501 New Delhi, Delhi, India
Tubeproducts U99999MH1990PLC056461 Mumbai, Maharashtra, India
Shanro Key Chem Industries Private Limited U24110MH1999PTC117799 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Jayanth Life Sciences Private Limited before audits and certifications: compliance score 51/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Jayanth Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 30/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 75/100, margin trends, ownership structure and peer set for Jayanth Life Sciences Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 68/100, distress signals and MSME payment-delay disclosures - know whether Jayanth Life Sciences Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Jayanth Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Jayanth Life Sciences Private Limited an active company?

Jayanth Life Sciences Private Limited has MCA status “Active” with a compliance score of 51/100 (Moderate).

Is Jayanth Life Sciences Private Limited financially healthy?

Jayanth Life Sciences Private Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Jayanth Life Sciences Private Limited?

Its overall Trust Score is 68/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Jayanth Life Sciences Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Jayanth Life Sciences Private Limited have loans or charges against its assets?

5 open charge(s) are registered against its assets, and 2 earlier charge(s) stand satisfied.

Is Jayanth Life Sciences Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 51/100 (Moderate).

Is it risky to lend to Jayanth Life Sciences Private Limited?

Its Credit Risk Score is 30/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.